OAKLAND, Calif., Oct. 13 /PRNewswire/ — The Care
Continuum Alliance honored Kaiser Permanente’s ALL/PHASE
initiative with the Quality Impact Award for the “Greatest Impact
on Health” at The Forum 10 conference today in
Washington, D.C. The ALL/PHASE protocol, which utilizes
low-cost and generic medications and clinical interventions to
reduce heart attacks, has been successfully implemented in Kaiser
Permanente communities, including those served by safety net
organizations.
“Kaiser Permanente’s ALL/PHASE protocol is an outstanding
example of the emphasis on quality embodied by this award,” said
Tracey Moorhead, president and CEO, Care Continuum Alliance. “We’re
pleased to honor this important initiative to improve population
health.”
Kaiser Permanente’s ALL initiative (Aspirin, Lisinopril and
Lipid-lowering medication) was implemented to reduce heart attacks
and strokes by aggressively enrolling patients with heart disease
or patients who are at least 55 years old with diabetes, in a
therapeutic program that included the use of these three
medications. The organization’s PHASE program (Preventing Heart
Attacks and Strokes Everyday) enhances ALL by adding a beta blocker
and emphasizing healthy lifestyle changes. Research has shown that
bundling two low-cost, generic heart drugs – a
cholesterol-lowering statin and a blood pressure-lowering drug
– prevents heart attack and stroke.
Realizing the benefits for its members and community partners,
Kaiser Permanente awarded Community Benefit grants to share this
initiative with safety net clinics. Those grants led to the
implementation of ALL in five community clinics in Southern
California, and the use of PHASE in seven community clinics and
four public hospital and health systems in Northern California.
“The ALL/PHASE initiative continues to be a proven keystone in
Kaiser Permanente’s cardio
‘/>”/>
